This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 May;129(5):593-596.

doi: 10.1016/j.ophtha.2022.02.022.

No authors listed

Published Erratum

No authors listed. Ophthalmology. 2022 May.

. 2022 May;129(5):593-596.

doi: 10.1016/j.ophtha.2022.02.022.

No abstract available

HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Dugel PU, Singh RP, Koh A, Ogura Y, Weissgerber G, Gedif K, Jaffe GJ, Tadayoni R, Schmidt-Erfurth U, Holz FG. Dugel PU, et al. Ophthalmology. 2021 Jan;128(1):89-99. doi: 10.1016/j.ophtha.2020.06.028. Epub 2020 Jun 20. Ophthalmology. 2021. PMID: 32574761 Clinical Trial.